Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Lung cancer survival inequality grows in England, ONS figures show

Widening gap between best and worst performing areas of England comes in contrast to shrinking inequalities for breast and bowel cancers

Alex Matthews-King
Health Correspondent
Tuesday 02 April 2019 09:29 BST
Comments
Issue of late diagnosis in lung cancer has led to screening programmes being launched in supermarket car parks
Issue of late diagnosis in lung cancer has led to screening programmes being launched in supermarket car parks (Getty)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The gap in lung cancer survival between the best and worst performing areas of England is growing, according to Office for National Statistics data.

Cancer survival statistics released on Monday show while overall cancer survival rates have improved since 2001 and inequalities have narrowed for breast and colon cancer survival, the gap for lung cancer has grown.

In the UK lung cancer kills more people than any other form of the disease and accounts for 21 per cent of all cancer deaths, 35,600 people a year or almost 100 a day.

Smoking is the biggest single factor than can increase a person’s chances and while smoking rates have been falling for decades many long-term smokers have already increased their risk – particularly in poorer areas.

In 2016, just 30.7 per cent of people diagnosed with lung cancer in Medway Clinical Commissioning Group (CCG) in Kent survived beyond one year, compared to 53.8 per cent of people in Westminster CCG, London – a gap of 23.1 percentage points.

This compares to 2001 when the gap was just 19.1 percentage points, ranging from 36.4 per cent to 17.3 per cent survival after one year.

Late diagnosis of lung cancer is a major challenge in improving survival and has led to the NHS rolling out screening centres in supermarket car parks where smokers and other high risk groups can be checked.

Despite this widening inequality, average lung cancer survival has improved from 26.3 per cent to 41.6 per cent, and in virtually all other areas the ONS data paints a picture of improving survival rates.

One year survival across all cancers rose from 62 per cent in 2001 to 72.8 per cent in 2016, and the average survival gap between the best and worst performing CCGs shrank.

In breast cancer near 97 per cent of women survive beyond one year, up from 93.3 per cent in 2001, and for colon cancer the rise is from 73.1 to 80.6 per cent.

“Where you live shouldn’t determine your chance of surviving lung cancer,” Dr Penny Woods, chief executive of the British Lung Foundation and chair of the Taskforce for Lung Health, said.

“Early diagnosis is key, as many people with lung disease remain undiagnosed or misdiagnosed for years and only learn of their condition when it’s too late for effective treatment.

Dr Woods added that the taskforce backs the roll out of the NHS mobile lung screening centres, but wants to see it nationwide.

She added: “When diagnosed at the earliest stage, more than one in three people with lung cancer will survive the disease for five years or more, compared with around five in 100 people when diagnosed at a later stage.”

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in